Malignant mesothelioma

R M Rudd1

  • 1London Lung Cancer Group, 54 New Cavendish Street, London, UK. dr@robinrudd.com

British Medical Bulletin
|January 6, 2010
PubMed
Abstract

Insights

Mesothelioma, a cancer linked to asbestos exposure, is becoming more common. While amphibole fibers are more potent carcinogens than chrysotile, new treatments offer hope.

Area of Science:

  • Oncology
  • Environmental Medicine
  • Pathology

Background:

  • Mesothelioma is a malignant tumor of the pleura or peritoneum.
  • It is primarily caused by asbestos exposure.
  • The incidence of mesothelioma is increasing, with a poor prognosis and short survival.

Purpose of the Study:

  • To review the current understanding of mesothelioma etiology and treatment.
  • To highlight areas of agreement and controversy in the field.
  • To discuss emerging research and future directions.

Main Methods:

  • Review of medical literature.
  • Incorporation of personal clinical experience.

Main Results:

  • Amphibole asbestos fibers are significantly more potent in causing mesothelioma than chrysotile.
  • A minority viewpoint suggests chrysotile-related mesotheliomas are due to tremolite contamination.
  • The hypothesis linking Simian virus 40 to mesothelioma is losing support.

Conclusions:

  • Genetic variations may influence susceptibility to asbestos-induced carcinogenesis.
  • Chemotherapy regimens, including pemetrexed and cisplatin, show promise in prolonging survival and managing symptoms.
  • Further research is needed on targeted therapies and the role of surgery.